This review highlights the lack of specific guideline recommendations for elderly patients with NSTE-ACS, who face higher thrombotic and bleeding risks, and suggests treatment options based on existing literature.
Answers are grounded in this paper and cite their sources.
Absence of elderly-specific NSTE-ACS guidelines warrants individualized risk assessment; leaves open dedicated trials to refine antithrombotic strategies.
Elderly patients with an acute coronary syndrome are underrepresented in randomised controlled trials. Neither the European Society of Cardiology nor the American Heart Association/American College of Cardiology acute coronary syndrome guidelines provide specific recommendations for elderly patients. However, elderly patients are at higher thrombotic and bleeding risk compared with younger patients leading to difficulties in choosing the optimal treatment. In this review, we discuss the uncertainties we encounter in treating elderly patients with non-ST-elevation acute coronary syndrome and suggest treatment options based on the existing literature.
No takes yet. Share an insight, caveat, or question.
Gimbel et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: